Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Now three quarters into its fiscal year, Ascension has chopped down its operating losses by more than half and more than tripped its bottom-line gain. | The nonprofit system's leadership described broadly improved performances across the health system’s acute care facilities and the fruit of a strategic expansion in outpatient access points.
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise

Even without counting the multi-billion hit tied to the early termination of a major joint venture and outsourcing arrangement,…

Ardent Health’s senior executives pushed back against concerns about softening volumes, promising that margin improvement…

Trinity Health is outperforming some of its large Catholic peers, reporting $200 million of operating income (1% operating…

Advocate Health started 2026 with a $380.1 million operating income (3.7% operating margin), up slightly from the $329.1 million…

Ascension’s $3.9 billion plan to acquire ambulatory surgery management services company AmSurg has received a green light from…

Alignment Healthcare delivered a strong second quarter, in what CEO John Kao said was supported by the deployment of its new…